Benzinga | Aug 4, 2021 07:36AM EDT

SVB Leerink Maintains Market Perform on Amgen, Lowers Price Target to $234

SVB Leerink analyst Geoffrey Porges maintains Amgen (NASDAQ:AMGN) with a Market Perform and lowers the price target from $238 to $234.